MX2017011648A - Metodos de piolisina y composiciones. - Google Patents

Metodos de piolisina y composiciones.

Info

Publication number
MX2017011648A
MX2017011648A MX2017011648A MX2017011648A MX2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A
Authority
MX
Mexico
Prior art keywords
methods
pyolysin
compositions
truepereiia
pyogenes
Prior art date
Application number
MX2017011648A
Other languages
English (en)
Inventor
Moutafis George
Poppe Allen
Herberg John
Andrew MOONEN Glenn
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2017011648A publication Critical patent/MX2017011648A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

En la presente, se describen métodos para medios de cultivo y condiciones de cultivo mejorados para Trueperella pyogenes, también se describen métodos mejorados para el aislamiento y la purificación de piolisina de Truepereila pyogenes.
MX2017011648A 2015-03-12 2016-03-14 Metodos de piolisina y composiciones. MX2017011648A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562132050P 2015-03-12 2015-03-12
PCT/US2016/022297 WO2016145432A1 (en) 2015-03-12 2016-03-14 Pyolysin methods and compositions

Publications (1)

Publication Number Publication Date
MX2017011648A true MX2017011648A (es) 2017-11-02

Family

ID=55640899

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011648A MX2017011648A (es) 2015-03-12 2016-03-14 Metodos de piolisina y composiciones.

Country Status (13)

Country Link
US (1) US10858401B2 (es)
EP (1) EP3268380B1 (es)
JP (1) JP6570648B2 (es)
KR (1) KR101999043B1 (es)
CN (1) CN107466326B (es)
AU (1) AU2016228514B2 (es)
BR (1) BR112017019460B1 (es)
CA (1) CA2979541C (es)
DK (1) DK3268380T3 (es)
ES (1) ES2711893T3 (es)
MX (1) MX2017011648A (es)
NZ (1) NZ734998A (es)
WO (1) WO2016145432A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107101933A (zh) * 2017-07-10 2017-08-29 郑州金域临床检验中心(普通合伙) 一种血液分析组合物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US5210037A (en) * 1988-03-22 1993-05-11 Centocor Incorporated Method to enhance TPA production
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
EP0837695A4 (en) * 1995-06-07 2001-03-21 Univ Kansas State ACTINOMYCES PYOGENES AND ACTINOMYCES PYOGENES / FUSOBAKTERIUM NECROPHORUM VACCINE FOR IMMUNIZING LIVESTOCK AND SHEEP
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
EP2032158A2 (en) * 2006-06-15 2009-03-11 Timothy John Mitchell Adjuvant compositions
LT5705B (en) * 2009-02-23 2011-01-25 Uab Profarma Monoclonal antibodies against vaginolysin
CA2893072C (en) * 2012-11-29 2023-10-03 Cornell University Vaccine for intrauterine disease
CN104073450A (zh) * 2014-02-28 2014-10-01 重庆市畜牧科学院 山羊源化脓隐秘杆菌及其应用
CN103937889B (zh) * 2014-04-14 2015-09-30 陕西省动物研究所 一种化脓隐秘杆菌lamp检测用引物及检测方法

Also Published As

Publication number Publication date
US10858401B2 (en) 2020-12-08
DK3268380T3 (en) 2019-02-18
BR112017019460B1 (pt) 2023-11-21
WO2016145432A1 (en) 2016-09-15
EP3268380A1 (en) 2018-01-17
JP6570648B2 (ja) 2019-09-04
BR112017019460A2 (pt) 2018-05-15
CN107466326B (zh) 2021-10-15
ES2711893T3 (es) 2019-05-08
US20180057543A1 (en) 2018-03-01
CN107466326A (zh) 2017-12-12
AU2016228514A1 (en) 2017-09-14
JP2018507704A (ja) 2018-03-22
KR101999043B1 (ko) 2019-07-10
EP3268380B1 (en) 2018-12-26
CA2979541A1 (en) 2016-09-15
KR20170126492A (ko) 2017-11-17
CA2979541C (en) 2019-07-16
NZ734998A (en) 2024-01-26
AU2016228514B2 (en) 2021-06-17

Similar Documents

Publication Publication Date Title
PH12018501159A1 (en) Composition and methods for immunooncology
AU2019264537A1 (en) Beta-lactamase inhibitors
PH12018501378A1 (en) Compositions and methods for the treatment of hemoglobinopathies
EP3383168A4 (en) METHOD FOR THE GENETIC MODIFICATION OF PLANTS
AU2016315655A8 (en) Ochrobactrum-mediated transformation of plants
EP3510140A4 (en) NEW CULTURE SYSTEM FOR EFFICIENT PRODUCTION OF MICROORGANISMS
MY184870A (en) Immunomodulators
MX2016013668A (es) Inhibidores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
MX2021014663A (es) Il-23a y tnf-alfa orientados y compuesto y sus usos.
MY182924A (en) Enzyme compositions and uses thereof
EP3584313A4 (en) PRESERVATION CULTURE OF INTESTINAL STEM CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS
EP3682009A4 (en) GENE EXPRESSION SYSTEM FOR PROBIOTIC MICROORGANISMS
EP3124602A4 (en) Culture medium for pluripotent stem cells
MX2017000527A (es) Formulaciones de anticuerpos cristalinos.
SG11201700361QA (en) Process for the purification of poliovirus from cell cultures
MX2021006003A (es) Formulaciones de anticuerpos cristalinos.
PT3296385T (pt) Sistema modular de fotobiorreatores para o cultivo de algas
SG10201908248PA (en) Processes for preparing fluoroketolides
IL274746A (en) A method for cell culture
EP3341112A4 (en) METHODS AND COMPOSITIONS FOR PROTEIN PURIFICATION AND REACTION OF AN ENZYME
BR112017024855A2 (pt) métodos de produção de aldc
EP3720942A4 (en) PHOTOBIOREACTOR FOR THE CULTURE OF THE MICRO-ORGANISMS CONTAINED
MX2017011648A (es) Metodos de piolisina y composiciones.
SG11201609623VA (en) Method of isolation of polyhydroxyaikanoates (phas) from biomass fermented by microorganisms producing polyhydroxyaikanoates (phas) and/or from biomass containing at least one crop-plant producing polyhydroxyaikanoates
EP3349688A4 (en) BIOREACTOR AND NACHSAATKAMMERSYSTEM AND CORRESPONDING METHOD THEREOF